English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53699434    線上人數 :  1692
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"huang c y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 461-485 / 2022 (共81頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-02-02T00:47:05Z Cytotoxicity of arsenic trioxide to transitional carcinoma cells Yeong-Shiau Pu;Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.; YEONG-SHIAU PU; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H.
臺大學術典藏 2021-02-02T00:47:05Z Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway Yeong-Shiau Pu;Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.; YEONG-SHIAU PU; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H.
臺大學術典藏 2021-02-02T00:47:04Z Changing trends of prostate cancer in Asia Yeong-Shiau Pu;Chiang H.-S.;Lin C.-C.;Huang C.-Y.;Huang K.-H.;Chen J.; YEONG-SHIAU PU; Chiang H.-S.; Lin C.-C.; Huang C.-Y.; Huang K.-H.; Chen J.
臺大學術典藏 2021-02-02T00:47:03Z Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide Hour T.-C.;Huang C.-Y.;Lin C.-C.;Chen J.;Guan J.-Y.;Lee J.-M.;Yeong-Shiau Pu; Hour T.-C.; Huang C.-Y.; Lin C.-C.; Chen J.; Guan J.-Y.; Lee J.-M.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:47:01Z Primary amyloidosis of the urinary bladder Huang C.-Y.;Shun C.-T.;Huang K.-H.;Chen J.;Yeong-Shiau Pu; Huang C.-Y.; Shun C.-T.; Huang K.-H.; Chen J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:47:01Z Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer Hour T.-C.;Yeong-Shiau Pu;Lin C.-C.;Huang S.-W.;Chen J.;Chiu A.W.;Chen C.-J.;Huang C.-Y.; Hour T.-C.; YEONG-SHIAU PU; Lin C.-C.; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; Huang C.-Y.
臺大學術典藏 2021-02-02T00:47:01Z Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells Yeong-Shiau Pu;Hsieh M.-W.;Wang C.-W.;Liu G.-Y.;Huang C.-Y.;Lin C.-C.;Guan J.-Y.;Lin S.-R.;Hour T.-C.; YEONG-SHIAU PU; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; Huang C.-Y.; Lin C.-C.; Guan J.-Y.; Lin S.-R.; Hour T.-C.
臺大學術典藏 2021-02-02T00:47:00Z Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:47:00Z High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan Huang P.-C.;Huang C.-Y.;Huang S.-W.;Lai M.-K.;Yu H.-J.;Chen J.;Yeong-Shiau Pu; Huang P.-C.; Huang C.-Y.; Huang S.-W.; Lai M.-K.; Yu H.-J.; Chen J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:59Z Malignant epithelioid angiomyolipoma of the kidney. Huang K.H.;Huang C.Y.;Chung S.D.;Yeong-Shiau Pu;Shun C.T.;Chen J.; Huang K.H.; Huang C.Y.; Chung S.D.; YEONG-SHIAU PU; Shun C.T.; Chen J.
臺大學術典藏 2021-02-02T00:46:59Z Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:59Z Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy Huang S.-P.;Huang C.-Y.;Wu W.-J.;Yeong-Shiau Pu;Chen J.;Chen Y.-Y.;Yu C.-C.;Wu T.T.;Wang J.-S.;Lee Y.-H.;Huang J.-K.;Huang C.-H.;Wu M.-T.; Huang S.-P.; Huang C.-Y.; Wu W.-J.; YEONG-SHIAU PU; Chen J.; Chen Y.-Y.; Yu C.-C.; Wu T.T.; Wang J.-S.; Lee Y.-H.; Huang J.-K.; Huang C.-H.; Wu M.-T.
臺大學術典藏 2021-02-02T00:46:58Z Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: A retrospective study of 1875 cases in Taiwan Chiang I.-N.;Chang S.-J.;Yeong-Shiau Pu;Huang K.-H.;Yu H.-J.;Huang C.-Y.; Chiang I.-N.; Chang S.-J.; YEONG-SHIAU PU; Huang K.-H.; Yu H.-J.; Huang C.-Y.
臺大學術典藏 2021-02-02T00:46:57Z Long-Term Follow-up of Hand-Assisted Laparoscopic Radical Nephrectomy for Organ-Confined Renal Cell Carcinoma Chung S.-D.; Huang K.-H.; Lai M.-K.; Huang C.-Y.; YEONG-SHIAU PU; Yu H.-J.; Chueh S.-C.
臺大學術典藏 2021-02-02T00:46:57Z Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:57Z Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial Lin C.-C.;Hsu C.-H.;Hour T.-C.;Cheng A.-L.;Huang C.-Y.;Huang K.-H.;Chen J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:57Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:56Z Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Yeong-Shiau Pu; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:56Z Long-term outcome of hand-assisted laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: Comparison with open surgery Chung S.-D.;Chueh S.-C.;Lai M.-K.;Huang C.-Y.;Yeong-Shiau Pu;Yu H.-J.;Huang K.-H.; Chung S.-D.; Chueh S.-C.; Lai M.-K.; Huang C.-Y.; YEONG-SHIAU PU; Yu H.-J.; Huang K.-H.
臺大學術典藏 2021-02-02T00:46:56Z Intermediate Follow-up of Hand-Assisted Retroperitoneoscopic Nephroureterectomy for Management of Upper Urinary Tract Urothelial Carcinoma: Comparison with Open Nephroureterectomy Chung S.-D.;Huang C.-Y.;Chueh S.-C.;Yeong-Shiau Pu;Lai M.-K.;Yu H.-J.;Huang K.-H.; Chung S.-D.; Huang C.-Y.; Chueh S.-C.; YEONG-SHIAU PU; Lai M.-K.; Yu H.-J.; Huang K.-H.
臺大學術典藏 2021-02-02T00:46:55Z CKD as a Risk Factor for Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma Chung S.-D.;Huang K.-H.;Lai M.-K.;Huang C.-Y.;Chen C.-H.;Yeong-Shiau Pu;Yu H.-J.;Chueh S.-C.; Chung S.-D.; Huang K.-H.; Lai M.-K.; Huang C.-Y.; Chen C.-H.; YEONG-SHIAU PU; Yu H.-J.; Chueh S.-C.
臺大學術典藏 2021-02-02T00:46:55Z Primary Mucinous Adenocarcinoma of Renal Pelvis with Carcinoembryonic Antigen Production Ho C.-H.; Lin W.-C.; YEONG-SHIAU PU; Yu H.-J.; Huang C.-Y.
臺大學術典藏 2021-02-02T00:46:55Z Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy Huang S.-P.;Huang C.-Y.;Wang J.-S.;Liu C.-C.;Yeong-Shiau Pu;Yu H.-J.;Yu C.-C.;Wu T.T.;Huang C.-H.;Wu W.-J.;Chou Y.-H.;Wu M.-T.; Huang S.-P.; Huang C.-Y.; Wang J.-S.; Liu C.-C.; YEONG-SHIAU PU; Yu H.-J.; Yu C.-C.; Wu T.T.; Huang C.-H.; Wu W.-J.; Chou Y.-H.; Wu M.-T.
臺大學術典藏 2021-02-02T00:46:54Z Comparison between hand-assisted laparoscopic and retroperitoneoscopic nephroureterectomy for the management of upper urinary tract urothelial carcinoma: Analysis of an intermediate follow-up period Chung S.-D.; Chueh S.-C.; Huang C.-Y.; Lai M.-K.; YEONG-SHIAU PU; Yu H.-J.; Huang K.-H.
臺大學術典藏 2021-02-02T00:46:52Z Characteristics of Female Non-Muscle-Invasive Bladder Cancer in Taiwan: Association with Upper Tract Urothelial Carcinoma and End-Stage Renal Disease Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; Yu H.-J.; YEONG-SHIAU PU

顯示項目 461-485 / 2022 (共81頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目